Moved into Permanent Home, SRI's CADRE Boosts Proteomics Work into Rx, Dx for Infectious Diseases | GenomeWeb

This story originally ran on Nov. 19.

By Tony Fong

SRI International has moved its Center for Advanced Drug Research to its new permanent home as it eyes bulking up its proteomics operations.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.